Home example 2 - Pharmamarketeer

overig

Ovarian cancer rates set to rise by 55%

Ahead of World Ovarian Cancer Day on 8 May, new figures have been released suggesting that rates of this type of cancer are set to greatly increase globally by nearly 55% over the next 20 years.

Pharmafile

2 x gelezen

onderzoek

Repurposed corticosteroid dexamethasone shown to reduce mortality in COVID-19 patients needing respiratory support

The University of Oxford has unveiled exciting new data in the treatment of the novel coronavirus, with a randomised clinical trial proving the efficacy of the corticosteroid dexamethasone in reducing mortality rates in...

InPharm.com

2 x gelezen

onderzoek

US to buy 100m doses of potential Covid-19 vaccine for $1.5bn

Potential Covid-19 vaccine
Moderna snares deal while undertaking phase 3 clinical trials of its experimental drug

The Financial Times

2 x gelezen

technologie

Kunstmatige intelligentie versnelt screening COVID-19

Screening COVID-19 Onderzoekers van de Technische Universiteit Eindhoven en het Catharina Ziekenhuis hebben een nieuw algoritme ontwikkeld dat heel snel COVID-19 in het bloed kan herkennen. De software is bedoeld voor...

Emerce

2 x gelezen

marketing

YoastCon 2019: Dé SEO & online marketing conferentie die je niet wilt missen!

Wil je alles weten over SEO & online marketing in 2019? Ga naar YoastCon op 7 en 8 februari in Nijmegen! Laat je inspireren en bijpraten door internationale experts uit diverse vakgebieden.

Dutch Cowboys

2 x gelezen

marketing

[column] Gooi je contentmarketing maar in de genderblender

Contentmarketing De volgende quote leen ik van emerce.nl uit een verhaal van Patricia van den Broek: ‘Bij welk magazine of online platform ik ook werkte, er was altijd één devies: houd het dichtbij. Dichtbij de...

MarketingTribune

2 x gelezen

onderzoek

AZ’s Imfinzi hits second major milestone at Phase 3 in unresectable lung cancer

AstraZeneca and its global biologics R&D MedImmune have lifted the curtain on new Phase 3 data for their immunotherapy Imfinzi (durvalumab) in the treatment of unresectable Stage III non-small cell lung cancer...

Pharmafile

2 x gelezen

overig

Keytruda continues success with new Phase 3 data in adjuvant melanoma

MSD has revealed new efficacy data for Keytruda (permbrolizumab) as an adjuvant therapy in the treatment of resected, high-risk stage III melanoma. It is the third such reveal in weeks, following the drug’s success as a...

Pharmafile

2 x gelezen

wet- en regelgeving

CytoSen receives favorable response from FDA to its pre-IND meeting package for CSTD002-NK

CytoSen Therapeutics, a private biopharmaceutical company accelerating innovation in Natural Killer cell therapy, today announced it has received a favorable response from the U.S. Food and Drug Administration to its...

News-Medical.Net

2 x gelezen

marketing

Is socialmedia-marketing een must? Jij bepaalt!

De laatste tijd hoor ik van steeds meer ondernemers dat ze socialmedia-moe zijn. Misschien herken je het wel, de haat-liefderelatie. Social media zijn bij uitstek geschikt om klanten te bereiken, maar je moet er steeds...

Frankwatching.nl

2 x gelezen

Latest articles

Ovarian cancer rates set to rise by 55%

Repurposed corticosteroid dexamethasone shown to reduce mortality in COVID-19 patients needing respiratory support

US to buy 100m doses of potential Covid-19 vaccine for $1.5bn

Kunstmatige intelligentie versnelt screening COVID-19

YoastCon 2019: Dé SEO & online marketing conferentie die je niet wilt missen!

[column] Gooi je contentmarketing maar in de genderblender

AZ’s Imfinzi hits second major milestone at Phase 3 in unresectable lung cancer

Keytruda continues success with new Phase 3 data in adjuvant melanoma

CytoSen receives favorable response from FDA to its pre-IND meeting package for CSTD002-NK

Is socialmedia-marketing een must? Jij bepaalt!

Wekelijkse highlights per e-mail

Algemene informatie